{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:06:34Z","timestamp":1786115194445,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002980","name":"Dalian University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JH2\/101700343"],"award-info":[{"award-number":["2023JH2\/101700343"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.05.021","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:44:23Z","timestamp":1779839063000},"page":"4794-4813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Programmable miRNA-guided RNA-toxin switch for selective elimination of cancer cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Xinghuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7015-8992","authenticated-orcid":false,"given":"Jiaqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.05.021_bib1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S2214-109X(20)30001-2","article-title":"Global burden of cancer attributable to infections: the critical role of implementation science","volume":"8","author":"Rositch","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ymthe.2026.05.021_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2026.05.021_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.semcancer.2022.01.005","article-title":"Immune checkpoint inhibitors in HCC: cellular, molecular and systemic data","volume":"86","author":"Harkus","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn9472","article-title":"AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models","volume":"17","author":"Ng","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.05.021_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.05.021_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.05.021_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.05.021_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41423-022-00848-3","article-title":"The combination of PD-1 blockade with interferon-\u03b1 has a synergistic effect on hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.021_bib10","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell-specific delivery of modified mRNA expressing therapeutic proteins to leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41422-023-00896-y","article-title":"Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells","volume":"34","author":"Shao","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2026.05.021_bib12","first-page":"385","article-title":"MicroRNA and liver cancer","volume":"3","author":"Onishi","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ymthe.2026.05.021_bib13","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.R900012200","article-title":"The RNA-induced silencing complex: a versatile gene-silencing machine","volume":"284","author":"Pratt","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.05.021_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep38311","article-title":"Biomarker microRNAs for diagnosis, prognosis and treatment of hepatocellular carcinoma: a functional survey and comparison","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.05.021_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep20065","article-title":"Differentially expressed miRNAs in hepatocellular carcinoma target genes in the genetic information processing and metabolism pathways","volume":"6","author":"Thurnherr","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.05.021_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cell.2014.10.002","article-title":"Toehold switches: De-novo-designed regulators of gene expression","volume":"159","author":"Green","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.021_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167689","article-title":"Engineering toehold-mediated switches for native RNA detection and regulation in bacteria","volume":"434","author":"Ekdahl","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/acssynbio.9b00343","article-title":"Orthogonal protein-responsive mRNA switches for mammalian synthetic biology","volume":"9","author":"Ono","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.omtn.2021.08.012","article-title":"Chimeric RNA-binding protein-based killing switch targeting hepatocellular carcinoma cells","volume":"25","author":"Yang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.05.021_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41589-018-0146-9","article-title":"Small-molecule-based regulation of RNA-delivered circuits in mammalian cells","volume":"14","author":"Wagner","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib21","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/s41467-018-07181-2","article-title":"Synthetic RNA-based logic computation in mammalian cells","volume":"9","author":"Matsuura","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib22","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41467-022-30172-3","article-title":"PERSIST platform provides programmable RNA regulation using CRISPR endoRNases","volume":"13","author":"DiAndreth","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41467-023-37540-7","article-title":"Programmable mammalian translational modulators by CRISPR-associated proteins","volume":"14","author":"Kawasaki","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41587-022-01534-5","article-title":"Programmable eukaryotic protein synthesis with RNA sensors by harnessing ADAR","volume":"41","author":"Jiang","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41587-022-01493-x","article-title":"Modular, programmable RNA sensing using ADAR editing in living cells","volume":"41","author":"Kaseniit","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","article-title":"Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs","volume":"37","author":"Qu","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib27","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41467-023-36851-z","article-title":"Autocatalytic base editing for RNA-responsive translational control","volume":"14","author":"Gayet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/acssynbio.8b00530","article-title":"A novel synthetic toehold switch for microRNA detection in mammalian cells","volume":"8","author":"Wang","year":"2019","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.stem.2015.04.005","article-title":"Efficient detection and purification of cell populations using synthetic microRNA switches","volume":"16","author":"Miki","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.05.021_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102450","article-title":"Development and characterization of a miRNA-responsive circular RNA expression system with cell type specificity","volume":"36","author":"Ma","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.05.021_bib31","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1038\/s41467-024-50600-w","article-title":"Conditional RNA interference in mammalian cells via RNA transactivation","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj1793","article-title":"A versatile and robust cell purification system with an RNA-only circuit composed of microRNA-responsive ON and OFF switches","volume":"8","author":"Fujita","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.05.021_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41556-019-0292-7","article-title":"A microRNA-inducible CRISPR\u2013Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool","volume":"21","author":"Wang","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102609","article-title":"MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control","volume":"36","author":"Masaki","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.05.021_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.05.021_bib36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-022-28279-8","article-title":"Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.021_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/nat.2018.0734","article-title":"MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct","volume":"28","author":"Jain","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2026.05.021_bib38","article-title":"Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.05.021_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.021_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified Lipid Nanoparticles for Tissue- And Cell-Targeted mRNA Delivery Facilitate Precision Tumor Therapy in a Lung Metastasis Mouse Model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2026.05.021_bib41","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1016\/j.cell.2024.08.007","article-title":"Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity","volume":"187","author":"Fontana","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.021_bib42","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41565-025-02045-5","article-title":"A modular mRNA platform for programmable induction of tumour-specific immunogenic cell death","volume":"20","author":"Dong","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2026.05.021_bib43","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucl. Acids Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:45:26Z","timestamp":1785977126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626004089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626004089"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmable miRNA-guided RNA-toxin switch for selective elimination of cancer cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}